The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis.

doi:10.1038/s41467-023-37184-7

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis.

Nature communications - 18 Mar 2023

Waller Natalie J E, Cheung Chen-Yi, Cook Gregory M, McNeil Matthew B

Abstract excerpt

The increasing incidence of drug resistance in Mycobacterium tuberculosis has diminished the efficacy of almost all available antibiotics, complicating efforts to combat the spread of this global health burden. Alongside the development of new drugs, optimised drug combinations are needed to improve treatment success and prevent the further spread of antibiotic resistance. Typically, antibiotic resistance leads...

Topics

Humans
Mycobacterium tuberculosis
Antitubercular Agents
Drug Resistance, Multiple, Bacterial
Tuberculosis
Phenotype
Microbial Sensitivity Tests
Tuberculosis, Multidrug-Resistant

Source

Open in PubMed Open full text

Identifiers

PMID: 36934122
DOI: 10.1038/s41467-023-37184-7
PMCID: PMC10024696

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics